Chiral Plasmonic Triangular Nanorings with SERS Activity for Ultrasensitive Detection of Amyloid Proteins in Alzheimer's Disease.
Adv Mater
; 33(38): e2102337, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-34309088
ABSTRACT
Chiral plasmonic nanomaterials have attracted unprecedented attention due to their broad applications in biomedicine, negative refractive index, and chiral sensing. Here, using a wet-chemistry process, chiral triangular Au nanorings are fabricated with a platinum (Pt) framework (l/d-Pt@Au triangular nanorings, named l/d-Pt@Au TNRs). The l/d-Pt@Au TNRs exhibit strong optical activity with a g-factor of 0.023 and can be used effectively for the discrimination of enantiomers due to selective resonance coupling between the induced electric and magnetic dipoles associated with enantiomers and the chiral plasmonic TNRs, also known as the surface-enhanced Raman scattering-chiral anisotropy (SERS-ChA) effect. The chiral d-Pt@Au TNRs represent a label-free SERS platform that can be applied to detect Aß monomers and fibrils, the hallmarks of Alzheimer's disease (AD), achieving a limit of detection (LOD) down to 0.045 × 10-12 m and 4 × 10-15 m for 42-residue-long amyloid-ß (Aß42 ) monomer and fibrils, respectively. Furthermore, chiral d-Pt@Au TNRs can also be successfully carried out to detect Aß42 proteins in AD patients with ultrahigh levels of sensitivity, thus allowing picogram quantities of Aß42 proteins to be identified. This research opens up an avenue for the use of chiral plasmonic nanomaterials as ultrasensitive SERS substrates to early diagnosis of protein-misfolding diseases.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Proteínas Amiloidogénicas
/
Enfermedad de Alzheimer
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Screening_studies
Idioma:
En
Revista:
Adv Mater
Asunto de la revista:
BIOFISICA
/
QUIMICA
Año:
2021
Tipo del documento:
Article